Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 

Assay kits can screen for epigenetic factors
December 2010
SHARING OPTIONS:

PerkinElmer Inc.

PerkinElmer Inc. has launched a panel of epigenetics-based detection reagents to enable high-throughput screening (HTS) for new drug candidates. The new assay kits can screen for epigenetic factors to assist researching diseases such as neurodegeneration and cancer. The new panel of reagents accelerates cancer and neurobiology research by facilitating screening for modulators of DNA activity. The new assays are designed to help researchers measure the activity of several epigenetic targets, such as histone methyltransferases (HMTs) and histone acetyltransferases (HATs) that methylate and acetylate histone peptides and proteins.
 
PerkinElmer Inc.
(800) 762-4000
www.perkinelmer.com
 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.